GLA
RMD icon

Good Life Advisors’s ResMed RMD Stock Holding History

Good Life Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$480K Sell
1,859
-21
-1% -$5.01K 0.03% 314
2025
Q1 		$421K Sell
1,880
-10
-0.5% -$2.33K 0.03% 328
2024
Q4 		$432K Sell
1,890
-1
-0.1% -$241 0.03% 321
2024
Q3 		$462K Buy
1,891
+3
+0.2% +$670 0.03% 363
2024
Q2 		$361K Buy
+1,888
New +$383K 0.03% 326

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Good Life Advisors's RMD Position: Q2 2025 in Review

Good Life Advisors reduced its ResMed (RMD) stake by 1.1% in Q2 2025, selling an estimated $5.01K and leaving 1,859 shares worth $480K. The position accounts for 0.03% of the portfolio, ranked #314.

Good Life Advisors first reported a position in RMD in Q2 2024 and has held it in 5 quarters since. 920 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Good Life Advisors held 1,859 shares of ResMed worth $480K as of Q2 2025.
  • Good Life Advisors sold 21 ResMed shares in Q2 2025, an estimated $5.01K.
  • ResMed made up 0.03% of Good Life Advisors's portfolio in Q2 2025, its #314 holding.
  • Good Life Advisors first reported a position in ResMed in Q2 2024 and has held it in 5 quarters since.
  • 920 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.